Authors

• Sara Milanović Litre — University Hospital of Split, Split, Croatia — ORCID: 0000-0003-3097-5047
• Kristina Šolić — University Hospital of Split, Split, Croatia

Keywords

transcatheter aortic valve implantation, aortic valve, nursing management

DOI

Full Text

Transcatheter aortic valve implantation (TAVI) is an accepted alternative method of treating severe aortic valve stenosis with a tendency to increase the number of procedures. (1) Unlike other procedural complications, the incidence of conduction disturbances has not decreased significantly despite technical improvements (about 10% with the latest generation of valves). (2) The connection between TAVI and conduction disturbances is determined by the anatomical proximity of the bundle of His and the annulus of the aortic valve. Transcatheter valve placement may cause edema, ischemia, or hematoma of the surrounding tissue near the conduction system. (3) The most common conduction disturbances are left bundle branch block and advanced atrioventricular block. (4) The most significant pre-procedural electrocardiographic risk factors for the occurrence of conduction disturbances are: right bundle branch block, present in 10-14% of patients, especially in combination with first degree AV block and bifascicular block. (5) Before the procedure, it is necessary to carefully review the previous electrocardiographic records, especially those of longer monitoring, because there is information that Holter monitoring the day before the procedure revealed AVB or significant bradycardia in a third of patients who received a pacemaker after the procedure. (6) Furthermore, the list of medications should be clearly recorded because there are indications that preoperative omission of beta blockers results in a lower incidence of ES implantation. (7) Procedural risk factors include the installation of a self-expanding valve (Evolut system), a deeper depth of valve installation and balloon postdilatation, which should be clearly indicated in the nursing documentation. (4) Conduction disturbances usually occur within 24 hours of the procedure, most often intraprocedurally, during valve expansion. The nursing handover should contain relevant information about the patient’s condition before, during and after the procedure. Vital signs, medications administered during the procedure, state of consciousness, difficulty with valve placement, type of valve, occurrence of arrhythmias and conduction disturbances during the procedure. The first step in planning health care after the TAVI procedure should refer to the assessment of the patient’s risk for the development of conduction disturbances. Nursing interventions should be focused on continuous monitoring of risk factors, evaluation of the patient’s status, observation of the electrocardiogram.

Literature

1. Siontis GC, Praz F, Pilgrim T, Mavridis D, Verma S, Salanti G, et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J. 2016 December 14;37(47):3503–12. https://doi.org/10.1093/eurheartj/ehw225
2. Corcione N, Berni A, Ferraro P, Morello A, Cimmino M, Albanese M, et al. Transcatheter aortic valve implantation with the novel-generation Navitor device: Procedural and early outcomes. Catheter Cardiovasc Interv. 2022 July;100(1):114–9. https://doi.org/10.1002/ccd.30179
3. Mangieri A, Montalto C, Pagnesi M, Lanzillo G, Demir O, Testa L, et al. TAVI and Post Procedural Cardiac Conduction Abnormalities. Front Cardiovasc Med. 2018 July 3;5:85. https://doi.org/10.3389/fcvm.2018.00085
4. Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021 September 14;42(35):3427–520. https://doi.org/10.1093/eurheartj/ehab364
5. Auffret V, Webb JG, Eltchaninoff H, Muñoz-García AJ, Himbert D, Tamburino C, et al. Clinical Impact of Baseline Right Bundle Branch Block in Patients Undergoing Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2017 August 14;10(15):1564–74. https://doi.org/10.1016/j.jcin.2017.05.030
6. Urena M, Hayek S, Cheema AN, Serra V, Amat-Santos IJ, Nombela-Franco L, et al. Arrhythmia burden in elderly patients with severe aortic stenosis as determined by continuous electrocardiographic recording: toward a better understanding of arrhythmic events after transcatheter aortic valve replacement. Circulation. 2015 February 3;131(5):469–77. https://doi.org/10.1161/CIRCULATIONAHA.114.011929
7. Younis A, Orvin K, Nof E, Barabash IM, Segev A, Berkovitch A, et al. The effect of periprocedural beta blocker withdrawal on arrhythmic risk following transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2019 June 1;93(7):1361–6. https://doi.org/10.1002/ccd.28017